ÂÜÀòÂÒÂ×

Dr. Khayrallah has been involved in pharmaceutical drug development for 30 years in executive as well as research and development positions. He acquired his experience in diverse pharmaceutical environments including large pharmaceutical, contract research, and biotechnology companies. Emergo Therapeutics is his fifth startup biopharmaceutical company in the last 11 years. He is also currently Chairman of the Board of Target Pharma Solutions, a clinical data company that works with pharmaceutical partners and the Food and Drug Administration to better understand the natural history of diseases, including treatment outcomes in the real world setting. Prior to these current positions, Dr. Khayrallah co-founded and led QuatroBio, LLC; Aerial BioPharma, LLC; Neuronex Inc.; Addrenex Pharmaceuticals, Inc.; and Alius Pharma, LLC. He also has held positions at Cytran, Inc., Lineberry Research Associates (later Constella Group and SRI International) in RTP, NC; Burroughs Wellcome Co. and later Glaxo Wellcome. He holds a Ph.D. degree in psychology from the University of North Carolina at Chapel Hill and a Bachelor’s degree in psychology from the American University of Beirut. Dr. Khayrallah is also actively involved with the entrepreneurial and social networks in the Research Triangle area of North Carolina.